Veeco Instruments Charts AI-Fueled Growth After Earnings

Veeco Instruments Inc ((VECO)) has held its Q1 earnings call. Read on for the main highlights of the call.

Veeco Instruments Inc.’s latest earnings call struck an upbeat tone, balancing sizeable strategic wins with manageable near‑term pressures. Executives underscored more than $250 million in indium phosphide–related orders, expanding AI‑linked opportunities and aggressive capacity plans, while downplaying temporary margin pressure, China headwinds and extended product evaluations.

Revenue and EPS Land Solidly Within Guidance

Veeco reported Q1 2026 revenue of $158 million, non‑GAAP operating income of $9 million and non‑GAAP diluted EPS of $0.14, all comfortably inside its guidance ranges. Management framed the quarter as a steady starting point for the year, with sequential softness in some segments but no change to the broader growth trajectory.

Silicon Photonics Orders Signal Strategic Breakthrough

A headline item was more than $250 million in new orders spanning MOCVD, wet processing and SPECTOR Ion Beam Deposition tools for indium phosphide laser manufacturing. Shipments start in Q3 2026 with the most significant ramp in Q1 2027, effectively locking in multi‑year demand tied to silicon photonics and AI data‑center build‑outs.

AI-Driven WFE Positioning Underpins Growth Story

Management highlighted differentiation in laser spike and nanosecond annealing, Ion Beam Deposition, wet processing and MOCVD as AI, high‑bandwidth memory and advanced packaging demand accelerates. The company reiterated its 2026 revenue outlook of $740 million to $800 million and non‑GAAP EPS of $1.50 to $1.85, banking on AI‑linked wafer fab equipment spending.

Capacity Expansion Targets SPECTOR and Wet Processing

To meet anticipated demand, Veeco plans to expand SPECTOR Ion Beam Deposition capacity roughly tenfold by early 2027, with the option to double again thereafter. Wet‑processing capacity will grow both onsite and through contract manufacturing, alongside broader footprint expansions, aiming to shorten lead times as orders stretch into 2027.

Large Long-Term Served Markets Support Multi-Year Upside

Veeco sized its 2030 served available markets at attractive levels, including $1.3 billion for annealing, $500 million for Ion Beam Deposition, EUV and pellicles, and $1.0 billion for advanced packaging. In compound semis, management sees about $700 million for indium phosphide lasers, $550 million for other photonics and $250 million for GaN power, reinforcing a long runway for growth.

Near-Term Outlook Stays Positive with Reiterated Guidance

For Q2, the company guided revenue to $170 million to $190 million, gross margin of 38% to 40% and EPS of $0.20 to $0.32 on about 64 million shares, implying sequential improvement. Executives reiterated full‑year 2026 guidance and said growth should accelerate in the second half of the year and into 2027 as major programs ramp.

Order Visibility Extends Well Into 2027

Veeco pointed to accelerated bookings and stronger customer engagement as key supports for visibility through 2027. Data storage, advanced packaging and the large indium phosphide laser orders all contribute to a fuller backlog, giving investors greater confidence in the durability of the company’s growth pipeline.

Gross Margin Hit by Licensing Delay on China Shipment

Q1 non‑GAAP gross margin slipped to about 36% from roughly 37.7% in the prior quarter, falling short of internal expectations. Management cited an approximately $8 million revenue shortfall tied to an LSA system shipment to China that was delayed by export licensing, which weighed on both top line and profitability for the period.

End-Market Revenue Shows Sequential Softness

Semiconductor revenue declined 1% quarter over quarter to $109 million, while compound semiconductor revenue fell 6% to $19 million and scientific and other dropped 16% to $20 million, with data storage flat at $10 million. The mix shift contributed to margin pressure, though management suggested that upcoming AI and photonics ramps should reverse the trend.

Working Capital Rises as Cash Buffer Remains Strong

Cash and short‑term investments edged down by $7 million to $383 million, even as accounts receivable jumped $40 million to $151 million and inventory increased $7 million to $282 million. Operating cash flow was $8 million and capital spending $5 million, indicating higher working capital needs as Veeco prepares for larger future shipments.

China Weakness and Mature-Node Exposure Drag

Revenue from China fell to about 13% of sales as mature‑node investments, especially for LSA tools at 40 and 28 nanometers, continued to decline. Management acknowledged that this headwind offsets some of the strength in AI‑related demand, making geographic and technology diversification increasingly important to the growth story.

Extended Evaluations Highlight Remaining Execution Work

Ion Beam Deposition evaluations for memory customers have been extended through the end of 2026 to address particle performance, automation and reliability, signaling more engineering work before broad, high‑volume adoption. SPECTOR lead times are roughly nine months, and major output increases are not expected until 2027, creating a lag between order momentum and revenue realization.

Axcelis Merger Faces Ongoing Regulatory Overhang

The proposed merger with Axcelis still requires antitrust clearance in China, which remains the last outstanding approval and a key source of deal uncertainty. Management continues to target a close in the second half of 2026, but investors must factor in regulatory risk alongside the strategic benefits of the combination.

Guidance Points to Stronger Second Half and 2027 Ramp

Veeco’s guidance calls for Q2 improvement in revenue and margins and reaffirms a robust full‑year 2026 outlook with accelerating growth in the back half. Management also highlighted that more than $250 million of indium phosphide–related orders will begin shipping in Q3 2026, with a major ramp in Q1 2027, supported by a planned tenfold SPECTOR capacity increase by early 2027.

Veeco’s earnings call presented a company leaning into AI, silicon photonics and advanced packaging just as those markets scale, even as China exposure, margin pressure and regulatory risks temper the near‑term picture. For investors, the story hinges on execution: if Veeco can deliver on its capacity, evaluations and merger plans, the multi‑year growth prospects outlined on the call look compelling.